Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$142.14

1.54 (1.10%)

09:21
11/06/18
11/06
09:21
11/06/18
09:21

Johnson & Johnson announces data from two studies of photochromic contact lenses

Johnson & Johnson Vision announced that data from two new studies on the visual effects of photochromic contact lenses will be presented at the 2018 American Academy of Optometry Annual Meeting in San Antonio. Both studies are among the 'most newsworthy' at the meeting, as selected by the American Academy of Optometry. These are the first scientific presentations focused on photochromic contact lens technology since the lenses received clearance from FDA in April.

  • 12

    Nov

JNJ Johnson & Johnson
$142.14

1.54 (1.10%)

10/29/18
MSCO
10/29/18
NO CHANGE
Target $153
MSCO
Equal Weight
Morgan Stanley says ruling on J&J's Zytiga patent not a surprise
Morgan Stanley analyst David Lewis said it was not a surprise that Johnson & Johnson lost a ruling over the patent of its prostate cancer drug Zytiga and he has already been expecting generics to enter the U.S. market after a 30-month stay expires this month. He forecasts a 50% decline in Zytiga in Q4 and while J&J did not specifically model a generic entry, Lewis believes its guidance range imbedded pressure from potential generic Zytiga competition. The analyst, who said trends and commentary last quarter made him more comfortable with his above-market forecast for 5%-6% Pharma growth in 2019 for Johnson & Johnson, keeps an Equal Weight rating on J&J shares.
10/25/18
WELS
10/25/18
NO CHANGE
WELS
Wells Fargo says Trump speech today won't be end of drug pricing proposals
Wells Fargo analyst David Maris notes that Politico and other media outlets are reporting that President Donald Trump will propose several new initiatives to address high drug prices when he speaks later today at the U.S. Department of Health and Human Services. Maris thinks Trump's focus will be on how other countries are "freeloading" on U.S. innovation with lower negotiated pricing, stating that news reports make it appear that the administration is targeting the industry for action, rather than other countries to raise their spending. While Maris acknowledges the timing of the speech being near the mid-term elections, he believes these proposals are simply the follow-though of earlier promises. He also expects this is not the end of proposals to address the issue of U.S. drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
10/24/18
JEFF
10/24/18
NO CHANGE
Target $50
JEFF
Buy
Pacira's strong Exparel trends continue, says Jefferies
Jefferies analyst David Steinberg says the 30.3% year-over-year gain for Symphony Health sales data in September suggests Pacira Pharmaceuticals' (PCRX) Exparel is continuing to accelerate. Exparel has now posted double digit year-over-year gains in 11 of the last 12 months arguably due to a strong nerve block launch and a Johnson & Johnson (JNJ) partnership that "may be hitting stride," Steinberg tells investors in a research note. The analyst sees the possibility for "significant upside" next year due to Centers for Medicare & Medicaid Services' unbundling in the ambulatory care setting. He keeps a Buy rating on Pacira with a $50 price target.
10/23/18
PIPR
10/23/18
NO CHANGE
PIPR
Overweight
Piper says Theravance data shows 'disruptive potential' of oral JAK inhibitor
After Theravance Biopharma (TBPH) presented four-week data from the Phase Ib ulcerative colitis study of TD-1473, a gut-selective pan-JAK inhibitor for the treatment of inflammatory bowel disease, at the United European Gastroenterology Week, Piper Jaffray analyst Tyler Van Buren said the data provides substantial proof of concept and shows the "disruptive potential" that could lead to "multi-billion" global sales for Theravance and partner Janssen (JNJ). He maintains an Overweight rating on Theravance shares.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$52.74

0.38 (0.73%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Periodicals
Departure of top Wells Fargo exec Hardison shows rift with regulator, WSJ says »

Hope Hardison, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

TRU

TransUnion

$64.43

-0.41 (-0.63%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Hot Stocks
TransUnion CEO James Peck to retire, Chris Cartwright to succeed »

TransUnion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Earnings
Canada Goose reports Q2 adjusted EPS 46c, consensus (7c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

, GIS

General Mills

$45.50

-0.2 (-0.44%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Downgrade
Kellogg, General Mills, Kraft Heinz rating change  »

JPMorgan downgrades…

K

Kellogg

$63.48

-0.81 (-1.26%)

GIS

General Mills

$45.50

-0.2 (-0.44%)

KHC

Kraft Heinz

$53.38

-0.29 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

06:45
11/14/18
11/14
06:45
11/14/18
06:45
General news
Breaking General news story  »

Week of 11/9 MBA Mortgage…

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

06:40
11/14/18
11/14
06:40
11/14/18
06:40
Downgrade
Jounce Therapeutics rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Periodicals
Amazon says over 10,000 workers are developing Alexa, Echo, WSJ reports »

Amazon has over 10,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

NOVN

Novan

$2.50

-0.04 (-1.57%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Hot Stocks
Novan Phase 2 molluscum contagiosum trial achieves statistical significance »

Novan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

LLESY

Lendlease Group

$0.00

(0.00%)

06:37
11/14/18
11/14
06:37
11/14/18
06:37
Upgrade
Lendlease Group rating change  »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.47

-0.03 (-0.14%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Syndicate
VICI Properties files to sell 25M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Earnings
Hollysys reports Q1 adjusted EPS 46c vs. 36c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Earnings
Astronics sees FY19 Aerospace revenue $710M-$745M »

"In our third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Upgrade
Hollysys rating change  »

Hollysys upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

, GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

06:34
11/14/18
11/14
06:34
11/14/18
06:34
Periodicals
Google to double New York City staff over next ten years, WSJ reports »

Google (GOOGL) has plans…

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Zymeworks updates clinical data for ZW25 anti-tumor candidate »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Astronics sells semiconductor test business to Advantest for $185M in cash »

Astronics announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SNAP

Snap

$6.72

0.06 (0.90%)

, FB

Facebook

$142.19

0.67 (0.47%)

06:32
11/14/18
11/14
06:32
11/14/18
06:32
Periodicals
Snap subpoenaed by DOJ, SEC over IPO disclosures, Reuters reports »

The U.S. Justice…

SNAP

Snap

$6.72

0.06 (0.90%)

FB

Facebook

$142.19

0.67 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

TSN

Tyson Foods

$58.16

-3.35 (-5.45%)

06:31
11/14/18
11/14
06:31
11/14/18
06:31
Recommendations
Tyson Foods analyst commentary  »

Tyson Foods shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

MANT

ManTech

$59.20

0.64 (1.09%)

06:29
11/14/18
11/14
06:29
11/14/18
06:29
Recommendations
ManTech analyst commentary  »

Attractive federal budget…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$35.19

-0.06 (-0.17%)

06:28
11/14/18
11/14
06:28
11/14/18
06:28
Downgrade
Conagra Brands rating change  »

Conagra Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$192.23

-1.925 (-0.99%)

, GLW

Corning

$32.03

0.32 (1.01%)

06:28
11/14/18
11/14
06:28
11/14/18
06:28
Downgrade
Apple, Corning, Lumentum rating change  »

Guggenheim sees 5% iPhone…

AAPL

Apple

$192.23

-1.925 (-0.99%)

GLW

Corning

$32.03

0.32 (1.01%)

LITE

Lumentum

$38.95

1.445 (3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

CDNA

CareDx

$25.49

-2.01 (-7.31%)

06:25
11/14/18
11/14
06:25
11/14/18
06:25
Syndicate
CareDx 2M share Spot Secondary priced at $24.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

  • 14

    Nov

TRCO

Tribune Media

$38.78

-0.575 (-1.46%)

, APO

Apollo Global

$29.00

-0.4 (-1.36%)

06:23
11/14/18
11/14
06:23
11/14/18
06:23
Periodicals
ION Media teams with Cerberus, Hicks in bid for Tribune, NY Post reports »

ION Media has joined…

TRCO

Tribune Media

$38.78

-0.575 (-1.46%)

APO

Apollo Global

$29.00

-0.4 (-1.36%)

NXST

Nexstar

$80.53

0.26 (0.32%)

SBGI

Sinclair Broadcast

$31.37

0.09 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

MOG.A

Moog

$79.24

0.09 (0.11%)

06:18
11/14/18
11/14
06:18
11/14/18
06:18
Upgrade
Moog rating change  »

Moog upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCOR

comScore

$17.44

0.33 (1.93%)

06:17
11/14/18
11/14
06:17
11/14/18
06:17
Recommendations
comScore analyst commentary  »

comScore can gain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.